Tonia Zemek

Ovarian cancer is an insidious disease, often known as a “silent-killer” as symptoms are vague and often strike without warning. Unlike many other cancers there is no early detection test. Consequently ovarian cancer is often diagnosed in its late stages and only 20%-30% of women will survive beyond five years of diagnosis. In comparison, survival rates increase to 80-100% when ovarian cancer is detected and treated early.

The Ovarian Cancer Research Foundation (OCRF) is Australia’s pre-eminent ovarian cancer research body. Our goal is to raise ovarian cancer awareness and vital funds for the development of an early detection test that will save women’s lives.

We receive no government funding and rely on the support of our community and business supporters to assist in driving our research forward.